Related Experiment Video
Updated: Jul 16, 2026
09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Disulfide-Crosslinked mPEG-PLA-(LA)4 Nanomicelles for Taxane Delivery in Breast Cancer Therapy
Yukun Xie1, Hao Wang1, Lanlan Xiang1
1Shanghai Key Laboratory of Advanced Polymeric Materials, School of Materials Science and Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.
Molecules (Basel, Switzerland)
|July 15, 2026
Summary
New nanomicelles improve breast cancer treatment by delivering hydrophobic taxanes like paclitaxel effectively. These injectable micelles show significant tumor inhibition in preclinical models, offering a promising delivery platform.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Taxanes are vital chemotherapy drugs for cancers, including breast cancer.
- Poor solubility and distribution limit the efficacy of paclitaxel, docetaxel, and cabazitaxel.
- Hydrophobic taxanes require advanced delivery systems for improved therapeutic outcomes.
Purpose of the Study:
- To develop a novel mPEG-PLA-(LA)4 nanomicelle carrier for hydrophobic taxanes.
- To enhance the aqueous compatibility and targeted delivery of paclitaxel, docetaxel, and cabazitaxel.
- To evaluate the anti-tumor efficacy of taxane-loaded nanomicelles against breast cancer xenografts.
Main Methods:
- Synthesis of mPEG-PLA-(LA)4 nanomicelles.
- Loading of paclitaxel, docetaxel, and cabazitaxel into nanomicelles.
- In vivo evaluation of nanomicelle therapeutic effects on MCF-7 human breast cancer xenografts in BALB/c nude mice.
Main Results:
- Successfully synthesized mPEG-PLA-(LA)4 nanomicelles capable of carrying hydrophobic taxanes.
- Injectable taxane-loaded nanomicelles demonstrated significant inhibition of MCF-7 xenograft tumor growth.
- The nanomicelle formulation improved the delivery and anti-tumor activity of the tested taxanes.
Conclusions:
- mPEG-PLA-(LA)4 nanomicelles represent a versatile and effective platform for delivering hydrophobic taxanes.
- This nanocarrier system shows potential for enhancing breast cancer chemotherapy.
- Further development could lead to improved taxane-based cancer therapies.
